Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…
Bristol Myers Squibb
(https://celgene.com) 📸 Data Snapshot: May 29, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Global Biopharmaceutical Company – Bristol Myers Squibb (https://celgene.com)
Title
Global Biopharmaceutical Company – Bristol Myers Squibb
Meta
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
H1 Global Biopharmaceutical Company – Bristol Myers Squibb
H2 Americas
H2 Asia Pacific
H2 Europe
H2 Middle East
H2 Other
H2 Patients & caregivers
H2 Healthcare providers
H2 Researchers
H2 Investors
H2 Business development
H2 News & media
H2 About us
H2 Explore BMS
H2 Defining what’s possible
H2 Looking for answers?
H2 Main navigation
H2 Resources
H2 Follow us
H3 Argentina
H3 Brazil
H3 Canada
H3 Chile
H3 Colombia
H3 Mexico
H3 Peru
H3 United States
H3 Australia
H3 China
H3 India
H3 Japan
H3 Korea
H3 New Zealand
H3 Singapore
H3 Taiwan
H3 Thailand
H3 Austria
H3 Belgium
H3 Czech Republic
H3 Denmark
H3 Finland
H3 France
H3 Germany
H3 Greece
H3 Hungary
H3 Ireland
H3 Italy
H3 Luxembourg
H3 Netherlands
H3 Norway
H3 Poland
H3 Portugal
H3 Romania
H3 Spain
H3 Sweden
H3 Switzerland
H3 United Kingdom
H3 Israel
H3 Saudi Arabia
H3 Turkey
H3 United Arab Emirates
H3 Other Markets
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Impact Report
H3 Survivorship Today
H3 Careers
H3 Investors
H3 Clinical Trial information for researchers
H3 Medical information for healthcare providers
H3 Help paying for your medicines
H4 2026 first quarter financial results
H4 Book’s story
H4 Champions in care
H4 Scientific media resources
H4 2025 Annual Report
H4 2025
H4 Building a Better Future
H5 Living with idiopathic pulmonary fibrosis: Jean-Michel's journey of strength, advocacy and hope
H5 Inside Devens: Advancing biopharmaceutical manufacturing through digital innovation
H5 Our scientists are chasing the next generation of treatment options for patients. Explore the ways we’re accelerating the development of new medicines with differentiated research platforms and a multitude of treatment modalities.
NAV_HEADER_HEADING_REPEATED_FOOTER Global Biopharmaceutical Company – Bristol Myers Squibb (https://celgene.com/patient-and-caregivers/our-medicines.html)
Title
Global Biopharmaceutical Company – Bristol Myers Squibb
Meta
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
H1 Global Biopharmaceutical Company – Bristol Myers Squibb
H2 Americas
H2 Asia Pacific
H2 Europe
H2 Middle East
H2 Other
H2 Patients & caregivers
H2 Healthcare providers
H2 Researchers
H2 Investors
H2 Business development
H2 News & media
H2 About us
H2 Explore BMS
H2 Defining what’s possible
H2 Looking for answers?
H2 Main navigation
H2 Resources
H2 Follow us
H3 Argentina
H3 Brazil
H3 Canada
H3 Chile
H3 Colombia
H3 Mexico
H3 Peru
H3 United States
H3 Australia
H3 China
H3 India
H3 Japan
H3 Korea
H3 New Zealand
H3 Singapore
H3 Taiwan
H3 Thailand
H3 Austria
H3 Belgium
H3 Czech Republic
H3 Denmark
H3 Finland
H3 France
H3 Germany
H3 Greece
H3 Hungary
H3 Ireland
H3 Italy
H3 Luxembourg
H3 Netherlands
H3 Norway
H3 Poland
H3 Portugal
H3 Romania
H3 Spain
H3 Sweden
H3 Switzerland
H3 United Kingdom
H3 Israel
H3 Saudi Arabia
H3 Turkey
H3 United Arab Emirates
H3 Other Markets
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Impact Report
H3 Survivorship Today
H3 Careers
H3 Investors
H3 Clinical Trial information for researchers
H3 Medical information for healthcare providers
H3 Help paying for your medicines
H4 2026 first quarter financial results
H4 Book’s story
H4 Champions in care
H4 Scientific media resources
H4 2025 Annual Report
H4 2025
H4 Building a Better Future
H5 Living with idiopathic pulmonary fibrosis: Jean-Michel's journey of strength, advocacy and hope
H5 Inside Devens: Advancing biopharmaceutical manufacturing through digital innovation
H5 Our scientists are chasing the next generation of treatment options for patients. Explore the ways we’re accelerating the development of new medicines with differentiated research platforms and a multitude of treatment modalities.
NAV_HEADER_HEADING_REPEATED_FOOTER Global Biopharmaceutical Company – Bristol Myers Squibb (https://celgene.com/life-and-science.html)
Title
Global Biopharmaceutical Company – Bristol Myers Squibb
Meta
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
H1 Global Biopharmaceutical Company – Bristol Myers Squibb
H2 Americas
H2 Asia Pacific
H2 Europe
H2 Middle East
H2 Other
H2 Patients & caregivers
H2 Healthcare providers
H2 Researchers
H2 Investors
H2 Business development
H2 News & media
H2 About us
H2 Explore BMS
H2 Defining what’s possible
H2 Looking for answers?
H2 Main navigation
H2 Resources
H2 Follow us
H3 Argentina
H3 Brazil
H3 Canada
H3 Chile
H3 Colombia
H3 Mexico
H3 Peru
H3 United States
H3 Australia
H3 China
H3 India
H3 Japan
H3 Korea
H3 New Zealand
H3 Singapore
H3 Taiwan
H3 Thailand
H3 Austria
H3 Belgium
H3 Czech Republic
H3 Denmark
H3 Finland
H3 France
H3 Germany
H3 Greece
H3 Hungary
H3 Ireland
H3 Italy
H3 Luxembourg
H3 Netherlands
H3 Norway
H3 Poland
H3 Portugal
H3 Romania
H3 Spain
H3 Sweden
H3 Switzerland
H3 United Kingdom
H3 Israel
H3 Saudi Arabia
H3 Turkey
H3 United Arab Emirates
H3 Other Markets
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Impact Report
H3 Survivorship Today
H3 Careers
H3 Investors
H3 Clinical Trial information for researchers
H3 Medical information for healthcare providers
H3 Help paying for your medicines
H4 2026 first quarter financial results
H4 Book’s story
H4 Champions in care
H4 Scientific media resources
H4 2025 Annual Report
H4 2025
H4 Building a Better Future
H5 Living with idiopathic pulmonary fibrosis: Jean-Michel's journey of strength, advocacy and hope
H5 Inside Devens: Advancing biopharmaceutical manufacturing through digital innovation
H5 Our scientists are chasing the next generation of treatment options for patients. Explore the ways we’re accelerating the development of new medicines with differentiated research platforms and a multitude of treatment modalities.
NAV_HEADER_HEADING_REPEATED_FOOTER Global Biopharmaceutical Company – Bristol Myers Squibb (https://celgene.com/about-us/contact-us.html)
Title
Global Biopharmaceutical Company – Bristol Myers Squibb
Meta
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
H1 Global Biopharmaceutical Company – Bristol Myers Squibb
H2 Americas
H2 Asia Pacific
H2 Europe
H2 Middle East
H2 Other
H2 Patients & caregivers
H2 Healthcare providers
H2 Researchers
H2 Investors
H2 Business development
H2 News & media
H2 About us
H2 Explore BMS
H2 Defining what’s possible
H2 Looking for answers?
H2 Main navigation
H2 Resources
H2 Follow us
H3 Argentina
H3 Brazil
H3 Canada
H3 Chile
H3 Colombia
H3 Mexico
H3 Peru
H3 United States
H3 Australia
H3 China
H3 India
H3 Japan
H3 Korea
H3 New Zealand
H3 Singapore
H3 Taiwan
H3 Thailand
H3 Austria
H3 Belgium
H3 Czech Republic
H3 Denmark
H3 Finland
H3 France
H3 Germany
H3 Greece
H3 Hungary
H3 Ireland
H3 Italy
H3 Luxembourg
H3 Netherlands
H3 Norway
H3 Poland
H3 Portugal
H3 Romania
H3 Spain
H3 Sweden
H3 Switzerland
H3 United Kingdom
H3 Israel
H3 Saudi Arabia
H3 Turkey
H3 United Arab Emirates
H3 Other Markets
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Related links
H3 Impact Report
H3 Survivorship Today
H3 Careers
H3 Investors
H3 Clinical Trial information for researchers
H3 Medical information for healthcare providers
H3 Help paying for your medicines
H4 2026 first quarter financial results
H4 Book’s story
H4 Champions in care
H4 Scientific media resources
H4 2025 Annual Report
H4 2025
H4 Building a Better Future
H5 Living with idiopathic pulmonary fibrosis: Jean-Michel's journey of strength, advocacy and hope
H5 Inside Devens: Advancing biopharmaceutical manufacturing through digital innovation
H5 Our scientists are chasing the next generation of treatment options for patients. Explore the ways we’re accelerating the development of new medicines with differentiated research platforms and a multitude of treatment modalities.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://celgene.com) Global Biopharmaceutical Company – Bristol Myers Squibb
[H1] Global Biopharmaceutical Company - Bristol Myers Squibb [IMG: Soccer player cheering] [H2] We Won't Lose When the stakes are high, we won't lose for our patients. Find out more at bmswontlose.com. [H2] Explore BMS [H4] 2026 first quarter financial results [H4] Book’s story [H4] Champions in care [H5] Living with idiopathic pulmonary fibrosis: Jean-Michel's journey of strength, advocacy and hope [H5] Inside Devens: Advancing biopharmaceutical manufacturing through digital innovation [H4] 2025 Annual Report [H2] Defining what’s possible [H3] Survivorship Today Explore what it means to live with cancer in a series of conversations with survivors from across the country. Learn more [H3] Careers Led by our passion for patients, we ignite innovation in science and in careers. Join us as we transform lives through science. Learn more [H3] Investors Learn about how we deliver for patients and shareholders in a way that embodies our values. Learn more [H2] Looking for answers? [H3] Clinical Trial information for researchers Clinical trials and research are a critical part of bringing new medicines to patients. Learn more Find a clinical trial [H3] Medical information for healthcare providers Information and resources to assist with caring for patients. Resources for U.S. healthcare providers Global medical information [H3] Help paying for your medicines If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help. Find out how
2411 chars
SUB-PAGE (https://celgene.com/patient-and-caregivers/our-medicines.html) Global Biopharmaceutical Company – Bristol Myers Squibb
[H1] Global Biopharmaceutical Company - Bristol Myers Squibb [IMG: Soccer player cheering] [H2] We Won't Lose When the stakes are high, we won't lose for our patients. Find out more at bmswontlose.com. [H2] Explore BMS [H4] 2026 first quarter financial results [H4] Book’s story [H4] Champions in care [H5] Living with idiopathic pulmonary fibrosis: Jean-Michel's journey of strength, advocacy and hope [H5] Inside Devens: Advancing biopharmaceutical manufacturing through digital innovation [H4] 2025 Annual Report [H2] Defining what’s possible [H3] Survivorship Today Explore what it means to live with cancer in a series of conversations with survivors from across the country. Learn more [H3] Careers Led by our passion for patients, we ignite innovation in science and in careers. Join us as we transform lives through science. Learn more [H3] Investors Learn about how we deliver for patients and shareholders in a way that embodies our values. Learn more [H2] Looking for answers? [H3] Clinical Trial information for researchers Clinical trials and research are a critical part of bringing new medicines to patients. Learn more Find a clinical trial [H3] Medical information for healthcare providers Information and resources to assist with caring for patients. Resources for U.S. healthcare providers Global medical information [H3] Help paying for your medicines If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help. Find out how
2411 chars
SUB-PAGE (https://celgene.com/life-and-science.html) Global Biopharmaceutical Company – Bristol Myers Squibb
[H1] Global Biopharmaceutical Company - Bristol Myers Squibb [IMG: Soccer player cheering] [H2] We Won't Lose When the stakes are high, we won't lose for our patients. Find out more at bmswontlose.com. [H2] Explore BMS [H4] 2026 first quarter financial results [H4] Book’s story [H4] Champions in care [H5] Living with idiopathic pulmonary fibrosis: Jean-Michel's journey of strength, advocacy and hope [H5] Inside Devens: Advancing biopharmaceutical manufacturing through digital innovation [H4] 2025 Annual Report [H2] Defining what’s possible [H3] Survivorship Today Explore what it means to live with cancer in a series of conversations with survivors from across the country. Learn more [H3] Careers Led by our passion for patients, we ignite innovation in science and in careers. Join us as we transform lives through science. Learn more [H3] Investors Learn about how we deliver for patients and shareholders in a way that embodies our values. Learn more [H2] Looking for answers? [H3] Clinical Trial information for researchers Clinical trials and research are a critical part of bringing new medicines to patients. Learn more Find a clinical trial [H3] Medical information for healthcare providers Information and resources to assist with caring for patients. Resources for U.S. healthcare providers Global medical information [H3] Help paying for your medicines If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help. Find out how
2411 chars
SUB-PAGE (https://celgene.com/about-us/contact-us.html) Global Biopharmaceutical Company – Bristol Myers Squibb
[H1] Global Biopharmaceutical Company - Bristol Myers Squibb [IMG: Soccer player cheering] [H2] We Won't Lose When the stakes are high, we won't lose for our patients. Find out more at bmswontlose.com. [H2] Explore BMS [H4] 2026 first quarter financial results [H4] Book’s story [H4] Champions in care [H5] Living with idiopathic pulmonary fibrosis: Jean-Michel's journey of strength, advocacy and hope [H5] Inside Devens: Advancing biopharmaceutical manufacturing through digital innovation [H4] 2025 Annual Report [H2] Defining what’s possible [H3] Survivorship Today Explore what it means to live with cancer in a series of conversations with survivors from across the country. Learn more [H3] Careers Led by our passion for patients, we ignite innovation in science and in careers. Join us as we transform lives through science. Learn more [H3] Investors Learn about how we deliver for patients and shareholders in a way that embodies our values. Learn more [H2] Looking for answers? [H3] Clinical Trial information for researchers Clinical trials and research are a critical part of bringing new medicines to patients. Learn more Find a clinical trial [H3] Medical information for healthcare providers Information and resources to assist with caring for patients. Resources for U.S. healthcare providers Global medical information [H3] Help paying for your medicines If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help. Find out how
2411 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
4Review mentions (all pages)
4External proof links (all pages)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 1 | 1 |
| /patient-and-caregivers/our-medicines.html | 1 | 1 |
| /life-and-science.html | 1 | 1 |
| /about-us/contact-us.html | 1 | 1 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
[
{
"itemListElement": [
{
"item": {
"name": "Global Biopharmaceutical Company - Bristol Myers Squibb",
"@id": "https://www.bms.com/"
},
"@type": "ListItem",
"position": 1
}
],
"@type": "BreadcrumbList",
"@context": "http://schema.org"
},
{
"@type": "WebPage",
"name": "Global Biopharmaceutical Company - Bristol Myers Squibb",
"description": "Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.",
"publisher": {
"@type": "Organization",
"name": "Bristol Myers Squibb"
},
"@context": "http://schema.org",
"URL": "https://www.bms.com/"
},
{
"address": {
"addressCountry": "United States",
"@type": "PostalAddress",
"postalCode": "10016",
"addressLocality": "New York",
"addressRegion": "NY"
},
"contactPoint": [
{
"areaServed": "United States",
"@type": "ContactPoint",
"contactOption": "General",
"name": "Bristol Myers Squibb",
"telephone": "1-800-332-2056",
"contactType": "Customer and Community Relations"
}
],
"@type": "Organization",
"name": "Bristol Myers Squibb",
"logo": "https://www.bms.com/assets/bms/us/en-us/images/bms-logo-social-default-card.jpg",
"description": "Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.",
"@context": "http://schema.org",
"url": "https://www.bms.com/",
"sameAs": [
"http://www.facebook.com/BristolMyersSquibb",
"https://www.instagram.com/bristolmyerssquibb/",
"http://twitter.com/BMSNEWS",
"http://www.linkedin.com/company/bristol-myers-squibb",
"http://www.youtube.com/bristolmyerssquibb"
]
},
{
"@type": "WebSite",
"potentialAction": {
"query-input": "required name=q",
"@type": "SearchAction",
"target": "https://www.bms.com/search-results.html?q={q}"
},
"@context": "http://schema.org",
"URL": "https://www.bms.com/"
}
]
/patient-and-caregivers/our-medicines.html
[
{
"itemListElement": [
{
"item": {
"name": "Global Biopharmaceutical Company - Bristol Myers Squibb",
"@id": "https://www.bms.com/"
},
"@type": "ListItem",
"position": 1
}
],
"@type": "BreadcrumbList",
"@context": "http://schema.org"
},
{
"@type": "WebPage",
"name": "Global Biopharmaceutical Company - Bristol Myers Squibb",
"description": "Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.",
"publisher": {
"@type": "Organization",
"name": "Bristol Myers Squibb"
},
"@context": "http://schema.org",
"URL": "https://www.bms.com/"
},
{
"address": {
"addressCountry": "United States",
"@type": "PostalAddress",
"postalCode": "10016",
"addressLocality": "New York",
"addressRegion": "NY"
},
"contactPoint": [
{
"areaServed": "United States",
"@type": "ContactPoint",
"contactOption": "General",
"name": "Bristol Myers Squibb",
"telephone": "1-800-332-2056",
"contactType": "Customer and Community Relations"
}
],
"@type": "Organization",
"name": "Bristol Myers Squibb",
"logo": "https://www.bms.com/assets/bms/us/en-us/images/bms-logo-social-default-card.jpg",
"description": "Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.",
"@context": "http://schema.org",
"url": "https://www.bms.com/",
"sameAs": [
"http://www.facebook.com/BristolMyersSquibb",
"https://www.instagram.com/bristolmyerssquibb/",
"http://twitter.com/BMSNEWS",
"http://www.linkedin.com/company/bristol-myers-squibb",
"http://www.youtube.com/bristolmyerssquibb"
]
},
{
"@type": "WebSite",
"potentialAction": {
"query-input": "required name=q",
"@type": "SearchAction",
"target": "https://www.bms.com/search-results.html?q={q}"
},
"@context": "http://schema.org",
"URL": "https://www.bms.com/"
}
]
/life-and-science.html
[
{
"itemListElement": [
{
"item": {
"name": "Global Biopharmaceutical Company - Bristol Myers Squibb",
"@id": "https://www.bms.com/"
},
"@type": "ListItem",
"position": 1
}
],
"@type": "BreadcrumbList",
"@context": "http://schema.org"
},
{
"@type": "WebPage",
"name": "Global Biopharmaceutical Company - Bristol Myers Squibb",
"description": "Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.",
"publisher": {
"@type": "Organization",
"name": "Bristol Myers Squibb"
},
"@context": "http://schema.org",
"URL": "https://www.bms.com/"
},
{
"address": {
"addressCountry": "United States",
"@type": "PostalAddress",
"postalCode": "10016",
"addressLocality": "New York",
"addressRegion": "NY"
},
"contactPoint": [
{
"areaServed": "United States",
"@type": "ContactPoint",
"contactOption": "General",
"name": "Bristol Myers Squibb",
"telephone": "1-800-332-2056",
"contactType": "Customer and Community Relations"
}
],
"@type": "Organization",
"name": "Bristol Myers Squibb",
"logo": "https://www.bms.com/assets/bms/us/en-us/images/bms-logo-social-default-card.jpg",
"description": "Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.",
"@context": "http://schema.org",
"url": "https://www.bms.com/",
"sameAs": [
"http://www.facebook.com/BristolMyersSquibb",
"https://www.instagram.com/bristolmyerssquibb/",
"http://twitter.com/BMSNEWS",
"http://www.linkedin.com/company/bristol-myers-squibb",
"http://www.youtube.com/bristolmyerssquibb"
]
},
{
"@type": "WebSite",
"potentialAction": {
"query-input": "required name=q",
"@type": "SearchAction",
"target": "https://www.bms.com/search-results.html?q={q}"
},
"@context": "http://schema.org",
"URL": "https://www.bms.com/"
}
]
/about-us/contact-us.html
[
{
"itemListElement": [
{
"item": {
"name": "Global Biopharmaceutical Company - Bristol Myers Squibb",
"@id": "https://www.bms.com/"
},
"@type": "ListItem",
"position": 1
}
],
"@type": "BreadcrumbList",
"@context": "http://schema.org"
},
{
"@type": "WebPage",
"name": "Global Biopharmaceutical Company - Bristol Myers Squibb",
"description": "Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.",
"publisher": {
"@type": "Organization",
"name": "Bristol Myers Squibb"
},
"@context": "http://schema.org",
"URL": "https://www.bms.com/"
},
{
"address": {
"addressCountry": "United States",
"@type": "PostalAddress",
"postalCode": "10016",
"addressLocality": "New York",
"addressRegion": "NY"
},
"contactPoint": [
{
"areaServed": "United States",
"@type": "ContactPoint",
"contactOption": "General",
"name": "Bristol Myers Squibb",
"telephone": "1-800-332-2056",
"contactType": "Customer and Community Relations"
}
],
"@type": "Organization",
"name": "Bristol Myers Squibb",
"logo": "https://www.bms.com/assets/bms/us/en-us/images/bms-logo-social-default-card.jpg",
"description": "Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.",
"@context": "http://schema.org",
"url": "https://www.bms.com/",
"sameAs": [
"http://www.facebook.com/BristolMyersSquibb",
"https://www.instagram.com/bristolmyerssquibb/",
"http://twitter.com/BMSNEWS",
"http://www.linkedin.com/company/bristol-myers-squibb",
"http://www.youtube.com/bristolmyerssquibb"
]
},
{
"@type": "WebSite",
"potentialAction": {
"query-input": "required name=q",
"@type": "SearchAction",
"target": "https://www.bms.com/search-results.html?q={q}"
},
"@context": "http://schema.org",
"URL": "https://www.bms.com/"
}
]
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Information Density
0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence
0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof
0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint
0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority
0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score
0 / 100
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Information Density
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Semantic Alignment
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Trust & Proof
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Commodity Fingerprint
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Identity & Authority
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS
Based on 784 businesses audited.
BS Detector
Medical Devices, Pharma & Biotech BS: Bristol Myers Squibb (celgene.com)
https://celgene.com
📍 Industry: Medical Devices, Pharma & Biotech
68
BS / 100
A high-gloss corporate shell that has undergone a ‘zombie’ migration, where sub-pages are merely technical echoes of the homepage. While the temporal markers are current, the substance-to-signal ratio is abysmal due to the total absence of product or scientific detail on pages specifically titled for those topics.
Info Density
Power-words vs. Substance ratio.
22
73% BS
Semantic Coherence
Homepage promise vs. Sub-page reality.
18
90% BS
Trust & Proof
Verifiable evidence vs. Trust Theatre.
10
50% BS
Commodity Fingerprint
Detection of industry clichés/templates.
12
80% BS
Identity & Authority
Expert verifiability & Schema depth.
6
40% BS
Immediately populate the ‘Our Medicines’ page with a structured database of products, indications, and safety information to resolve the current content clone. Replace the slogan-heavy H2 headings like ‘Defining what’s possible’ with specific technical or therapeutic area markers. Integrate published clinical trial citations and peer-reviewed study links directly onto the ‘Life and Science’ page. Implement Person schema for key scientific leadership to bridge the authority gap.
The content perfectly aligns with the Biopharmaceutical and Biotech industry, referencing clinical trials, patient advocacy, and large-scale manufacturing. However, the site effectively functions as a corporate placeholder for Bristol Myers Squibb rather than a standalone entity for Celgene.
“The score of 68 is driven primarily by the Semantic Coherence and Information Density pillars. The failure of sub-pages to deliver on their URL-indicated topics (Medicines/Science) and the heavy reliance on industry clichés significantly inflated the BS detection metrics.”
Verified Analysis Date: May 29, 2026
© 1EuroSEO Independent Evaluator — Non-Sponsored Result
Analysis Disclosure & Source Attribution
This training module utilizes a snapshot of public data from Bristol Myers Squibb, captured on May 29, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Bristol Myers Squibb: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://celgene.com to view the most current version of its content and learn from the source what this company is about and what it offers.